NVO
Novo Nordisk A/S · Healthcare · Drug Manufacturers - General
Momentum-Eingaben (vergleichbare Manager):
Halterbreite -5.0% ·
Aktienfluss -2.8% ·
neue Nettopositionen -5.3%
· Formel
Breite Distribution: sinkende Aktienanzahl und weniger Inhaber
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 347.39K | $13.21M | n/a | n/a |
| Q2 2026 | 132 | 0 | 235.88M | $11.31B | +12 | −13 |
| Q1 2026 | 134 | -8 | 242.80M | $8.91B | +5 | −13 |
| Q4 2025 | 140 | +1 | 228.46M | $11.63B | +3 | −2 |
| Q3 2025 | 19 | -1 | 80.89M | $4.49B | +2 | −3 |
| Q2 2025 | 17 | -1 | 53.30M | $3.68B | +1 | −2 |
| Q1 2025 | 16 | 0 | 43.10M | $3.00B | n/a | n/a |
| Q4 2024 | 16 | -1 | 48.20M | $4.15B | +1 | −2 |
| Q3 2024 | 16 | -1 | 43.13M | $5.09B | +1 | −2 |
| Q2 2024 | 17 | n/a | 46.04M | $6.57B | n/a | n/a |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 14.08M | +1.0% | $781.04M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 2 | Morgan Stanley ✦ | 12.41M | n/a | $688.82M | 0.0% | n/c | 1 | SEC ↗ ×14 |
| 3 | JPMorgan Chase ✦ | 10.82M | n/a | $600.22M | 0.0% | n/c | 1 | SEC ↗ ×32 |
| 4 | Fisher Asset Management ✦ | 10.32M | -6.2% | $572.82M | 0.2% | ▼ Trim | 6 | SEC ↗ |
| 5 | Goldman Sachs Group ✦ | 6.72M | n/a | $372.69M | 0.1% | n/c | 1 | SEC ↗ ×3 |
| 6 | State Street Global Advisors ✦ (passiv) | 6.11M | +1.0% | $340.12M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | T. Rowe Price ✦ | 4.85M | -21.8% | $269.24M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 8 | BlackRock ✦ (passiv) | 3.96M | -9.1% | $219.95M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 9 | Citadel Advisors ✦ | 3.13M | +690.0% | $173.80M | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 10 | Renaissance Technologies ✦ | 2.88M | -41.6% | $159.92M | 0.2% | ▼ Trim | 6 | SEC ↗ |
| 11 | Markel Group ✦ | 2.37M | +4.9% | $131.44M | 1.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 12 | Two Sigma Investments ✦ | 1.69M | -23.7% | $93.86M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 1.05M | Neu | $58.24M | 0.1% | New | 1 | SEC ↗ |
| 14 | Capital World Investors ✦ | 210.86K | -2.2% | $11.70M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 15 | Bridgewater Associates ✦ | 138.95K | Neu | $7.71M | 0.0% | New | 1 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 123.80K | -1.3% | $6.87M | 0.0% | ▼ Trim | 6 | SEC ↗ ×3 |
| 17 | Millennium Management ✦ | 23.90K | -33.0% | $1.33M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 18 | GAMCO Investors ✦ | 4.14K | -8.8% | $229,951 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | Baillie Gifford ✦ | 314 | +141.5% | $17,424 | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
„Ihr Gewicht" = Anteil der Position am gemeldeten 13F-Aktienwert des Managers: das Überzeugungsmaß. ✦ = kuratorisch betreuter Manager.
Neue Käufer
| D. E. Shaw & Co. | $58.24M | 0.1% |
| Bridgewater Associates | $7.71M | 0.0% |
Ausgestiegen
| Tiger Global Management | $87.59M | war 0.3% |
| Wellington Management | $17.99M | war 0.0% |
| Marshall Wace | $2.15M | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 1 Inhaber, 1.21M Anteile, $43.09M gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten: gemeinsame Eigentümerzahlen, keine fundamentalen Beziehungen.